Partial nephrectomy for renal masses ≥7 cm: Technical, oncological and functional outcomes

Christopher J. Long, Daniel J. Canter, Alexander Kutikov, Tianyu Li, Jay Simhan, Marc Smaldone, Ervin Teper, Rosalia Viterbo, Stephen A. Boorjian, David Y T Chen, Richard E. Greenberg, Robert G. Uzzo

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

What's known on the subject? and What does the study add? Partial nephrectomy for the pT1 renal mass has demonstrated acceptable oncological outcomes in addition to improved overall long-term survival when compared with radical nephrectomy. Previous reports for lesions ≥7 cm have shown mixed data concerning oncological outcomes and technological success. We demonstrate that partial nephrectomy for renal masses ≥7 cm has acceptable oncological, technical, and functional outcomes. As such, partial nephrectomy should be a surgical option when feasible regardless of tumour size. Study Type - Therapy (case series) Level of Evidence 4 OBJECTIVE To present outcomes for patients with renal masses ≥7 cm in size who are treated with partial nephrectomy (PN) at our institution and to summarize the cumulative published experience. PATIENTS AND METHODS We reviewed our prospectively maintained institutional kidney cancer database and identified patients undergoing PN for tumours >7 cm in size. Technical, oncological and renal functional data were analyzed and compared with the existing published experience of PNs for tumours >7 cm in size. RESULTS In total, 46 patients with 49 renal tumours >7 cm in size who underwent PN were identified. With a median (range) follow-up of 13.1 (0.2-170.0) months, there were 16 complications, including four (8.2%) blood transfusions and six (12.2%) urinary fistulae. The 5- and 10-year overall and renal cell carcinoma (RCC)-specific survivals were 94.5% and 70.9%. There were five (10.9%) patients who had an upward migration in their chronic kidney disease status after PN. There were six previous series totalling 280 tumours encompassing the published experience of PN for tumours >7 cm in size. The incidence of urinary fistulae and postoperative haemorrhage, respectively, was in the range 3.3-18.8% and 0-3%. Although oncological outcomes showed cancer-specific survival in the range 66-97.0%, series matching PN and RN in patients with T2 RCC show equivalency in RCC-specific and overall survivals. When reported, PN for tumours >7 cm in size was associated with better renal functional preservation. CONCLUSION The findings of the present study show that PN can safely be performed in tumours ≥7 cm in size with acceptable technical, oncological and functional outcomes. Further studies are warranted.

Original languageEnglish (US)
Pages (from-to)1450-1456
Number of pages7
JournalBJU International
Volume109
Issue number10
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Nephrectomy
Kidney
Neoplasms
Urinary Fistula
Renal Cell Carcinoma
Survival
Postoperative Hemorrhage
Kidney Neoplasms
Chronic Renal Insufficiency
Blood Transfusion
Databases

Keywords

  • 7 cm
  • partial nephrectomy
  • pT2
  • renal function

ASJC Scopus subject areas

  • Urology

Cite this

Long, C. J., Canter, D. J., Kutikov, A., Li, T., Simhan, J., Smaldone, M., ... Uzzo, R. G. (2012). Partial nephrectomy for renal masses ≥7 cm: Technical, oncological and functional outcomes. BJU International, 109(10), 1450-1456. https://doi.org/10.1111/j.1464-410X.2011.10608.x

Partial nephrectomy for renal masses ≥7 cm : Technical, oncological and functional outcomes. / Long, Christopher J.; Canter, Daniel J.; Kutikov, Alexander; Li, Tianyu; Simhan, Jay; Smaldone, Marc; Teper, Ervin; Viterbo, Rosalia; Boorjian, Stephen A.; Chen, David Y T; Greenberg, Richard E.; Uzzo, Robert G.

In: BJU International, Vol. 109, No. 10, 05.2012, p. 1450-1456.

Research output: Contribution to journalArticle

Long, CJ, Canter, DJ, Kutikov, A, Li, T, Simhan, J, Smaldone, M, Teper, E, Viterbo, R, Boorjian, SA, Chen, DYT, Greenberg, RE & Uzzo, RG 2012, 'Partial nephrectomy for renal masses ≥7 cm: Technical, oncological and functional outcomes', BJU International, vol. 109, no. 10, pp. 1450-1456. https://doi.org/10.1111/j.1464-410X.2011.10608.x
Long, Christopher J. ; Canter, Daniel J. ; Kutikov, Alexander ; Li, Tianyu ; Simhan, Jay ; Smaldone, Marc ; Teper, Ervin ; Viterbo, Rosalia ; Boorjian, Stephen A. ; Chen, David Y T ; Greenberg, Richard E. ; Uzzo, Robert G. / Partial nephrectomy for renal masses ≥7 cm : Technical, oncological and functional outcomes. In: BJU International. 2012 ; Vol. 109, No. 10. pp. 1450-1456.
@article{79bedb8651f84981b3887e2843ee2700,
title = "Partial nephrectomy for renal masses ≥7 cm: Technical, oncological and functional outcomes",
abstract = "What's known on the subject? and What does the study add? Partial nephrectomy for the pT1 renal mass has demonstrated acceptable oncological outcomes in addition to improved overall long-term survival when compared with radical nephrectomy. Previous reports for lesions ≥7 cm have shown mixed data concerning oncological outcomes and technological success. We demonstrate that partial nephrectomy for renal masses ≥7 cm has acceptable oncological, technical, and functional outcomes. As such, partial nephrectomy should be a surgical option when feasible regardless of tumour size. Study Type - Therapy (case series) Level of Evidence 4 OBJECTIVE To present outcomes for patients with renal masses ≥7 cm in size who are treated with partial nephrectomy (PN) at our institution and to summarize the cumulative published experience. PATIENTS AND METHODS We reviewed our prospectively maintained institutional kidney cancer database and identified patients undergoing PN for tumours >7 cm in size. Technical, oncological and renal functional data were analyzed and compared with the existing published experience of PNs for tumours >7 cm in size. RESULTS In total, 46 patients with 49 renal tumours >7 cm in size who underwent PN were identified. With a median (range) follow-up of 13.1 (0.2-170.0) months, there were 16 complications, including four (8.2{\%}) blood transfusions and six (12.2{\%}) urinary fistulae. The 5- and 10-year overall and renal cell carcinoma (RCC)-specific survivals were 94.5{\%} and 70.9{\%}. There were five (10.9{\%}) patients who had an upward migration in their chronic kidney disease status after PN. There were six previous series totalling 280 tumours encompassing the published experience of PN for tumours >7 cm in size. The incidence of urinary fistulae and postoperative haemorrhage, respectively, was in the range 3.3-18.8{\%} and 0-3{\%}. Although oncological outcomes showed cancer-specific survival in the range 66-97.0{\%}, series matching PN and RN in patients with T2 RCC show equivalency in RCC-specific and overall survivals. When reported, PN for tumours >7 cm in size was associated with better renal functional preservation. CONCLUSION The findings of the present study show that PN can safely be performed in tumours ≥7 cm in size with acceptable technical, oncological and functional outcomes. Further studies are warranted.",
keywords = "7 cm, partial nephrectomy, pT2, renal function",
author = "Long, {Christopher J.} and Canter, {Daniel J.} and Alexander Kutikov and Tianyu Li and Jay Simhan and Marc Smaldone and Ervin Teper and Rosalia Viterbo and Boorjian, {Stephen A.} and Chen, {David Y T} and Greenberg, {Richard E.} and Uzzo, {Robert G.}",
year = "2012",
month = "5",
doi = "10.1111/j.1464-410X.2011.10608.x",
language = "English (US)",
volume = "109",
pages = "1450--1456",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Partial nephrectomy for renal masses ≥7 cm

T2 - Technical, oncological and functional outcomes

AU - Long, Christopher J.

AU - Canter, Daniel J.

AU - Kutikov, Alexander

AU - Li, Tianyu

AU - Simhan, Jay

AU - Smaldone, Marc

AU - Teper, Ervin

AU - Viterbo, Rosalia

AU - Boorjian, Stephen A.

AU - Chen, David Y T

AU - Greenberg, Richard E.

AU - Uzzo, Robert G.

PY - 2012/5

Y1 - 2012/5

N2 - What's known on the subject? and What does the study add? Partial nephrectomy for the pT1 renal mass has demonstrated acceptable oncological outcomes in addition to improved overall long-term survival when compared with radical nephrectomy. Previous reports for lesions ≥7 cm have shown mixed data concerning oncological outcomes and technological success. We demonstrate that partial nephrectomy for renal masses ≥7 cm has acceptable oncological, technical, and functional outcomes. As such, partial nephrectomy should be a surgical option when feasible regardless of tumour size. Study Type - Therapy (case series) Level of Evidence 4 OBJECTIVE To present outcomes for patients with renal masses ≥7 cm in size who are treated with partial nephrectomy (PN) at our institution and to summarize the cumulative published experience. PATIENTS AND METHODS We reviewed our prospectively maintained institutional kidney cancer database and identified patients undergoing PN for tumours >7 cm in size. Technical, oncological and renal functional data were analyzed and compared with the existing published experience of PNs for tumours >7 cm in size. RESULTS In total, 46 patients with 49 renal tumours >7 cm in size who underwent PN were identified. With a median (range) follow-up of 13.1 (0.2-170.0) months, there were 16 complications, including four (8.2%) blood transfusions and six (12.2%) urinary fistulae. The 5- and 10-year overall and renal cell carcinoma (RCC)-specific survivals were 94.5% and 70.9%. There were five (10.9%) patients who had an upward migration in their chronic kidney disease status after PN. There were six previous series totalling 280 tumours encompassing the published experience of PN for tumours >7 cm in size. The incidence of urinary fistulae and postoperative haemorrhage, respectively, was in the range 3.3-18.8% and 0-3%. Although oncological outcomes showed cancer-specific survival in the range 66-97.0%, series matching PN and RN in patients with T2 RCC show equivalency in RCC-specific and overall survivals. When reported, PN for tumours >7 cm in size was associated with better renal functional preservation. CONCLUSION The findings of the present study show that PN can safely be performed in tumours ≥7 cm in size with acceptable technical, oncological and functional outcomes. Further studies are warranted.

AB - What's known on the subject? and What does the study add? Partial nephrectomy for the pT1 renal mass has demonstrated acceptable oncological outcomes in addition to improved overall long-term survival when compared with radical nephrectomy. Previous reports for lesions ≥7 cm have shown mixed data concerning oncological outcomes and technological success. We demonstrate that partial nephrectomy for renal masses ≥7 cm has acceptable oncological, technical, and functional outcomes. As such, partial nephrectomy should be a surgical option when feasible regardless of tumour size. Study Type - Therapy (case series) Level of Evidence 4 OBJECTIVE To present outcomes for patients with renal masses ≥7 cm in size who are treated with partial nephrectomy (PN) at our institution and to summarize the cumulative published experience. PATIENTS AND METHODS We reviewed our prospectively maintained institutional kidney cancer database and identified patients undergoing PN for tumours >7 cm in size. Technical, oncological and renal functional data were analyzed and compared with the existing published experience of PNs for tumours >7 cm in size. RESULTS In total, 46 patients with 49 renal tumours >7 cm in size who underwent PN were identified. With a median (range) follow-up of 13.1 (0.2-170.0) months, there were 16 complications, including four (8.2%) blood transfusions and six (12.2%) urinary fistulae. The 5- and 10-year overall and renal cell carcinoma (RCC)-specific survivals were 94.5% and 70.9%. There were five (10.9%) patients who had an upward migration in their chronic kidney disease status after PN. There were six previous series totalling 280 tumours encompassing the published experience of PN for tumours >7 cm in size. The incidence of urinary fistulae and postoperative haemorrhage, respectively, was in the range 3.3-18.8% and 0-3%. Although oncological outcomes showed cancer-specific survival in the range 66-97.0%, series matching PN and RN in patients with T2 RCC show equivalency in RCC-specific and overall survivals. When reported, PN for tumours >7 cm in size was associated with better renal functional preservation. CONCLUSION The findings of the present study show that PN can safely be performed in tumours ≥7 cm in size with acceptable technical, oncological and functional outcomes. Further studies are warranted.

KW - 7 cm

KW - partial nephrectomy

KW - pT2

KW - renal function

UR - http://www.scopus.com/inward/record.url?scp=84860334132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860334132&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2011.10608.x

DO - 10.1111/j.1464-410X.2011.10608.x

M3 - Article

C2 - 22221502

AN - SCOPUS:84860334132

VL - 109

SP - 1450

EP - 1456

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 10

ER -